Loading…
Reported covered position: Chief of Staff, Rep. Linda Sanchez
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Chronic Kidney Disease Improvement in Research and Treatment Act of 2015
Client: DAVITA INC. · Firm: PURPLE ADVOCACY, LLC
CMS call letter for Medicare Advantage with a focus on rate setting and risk adjustment CMS regulations related to the treatment of Medicare Part C and Part D CMS regulations pertaining to reimbursement rates for ESRD-related services. H.R. 2 the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) (All provisions) S. 598 Chronic Kidney Disease Improvement in Research and Treatment Act of 2015 (All provisions) H.R. 1130 Chronic Kidney Disease Improvement in Research and Treatment Act of 2015 (All provisions)
Chronic Kidney Disease Improvement in Research and Treatment Act of 2015
Client: DAVITA INC. · Firm: PURPLE ADVOCACY, LLC
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
NATIONAL ASSOCIATION FOR STOCK CAR AUTO RACING via PURPLE ADVOCACY, LLC
2015 · fourth_quarter · 4T
Issue education related to the depreciation of motorsports entertainment complex facilities
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HUNTINGTON INGALLS INDUSTRIES INC. via PURPLE ADVOCACY, LLC
2015 · fourth_quarter · 4T
Source: Senate LDA
| NATIONAL RETAIL FEDERATION |
| 2 |
| 2012 |
| TENNESSEE WALKING SHOW HORSE ORGANIZATION | 2 | 2012 |
CMS call letter for Medicare Advantage with a focus on rate setting and risk adjustment CMS regulations related to the treatment of Medicare Part C and Part D CMS regulations pertaining to reimbursement rates for ESRD-related services. H.R. 2 the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) (All provisions) S. 598 Chronic Kidney Disease Improvement in Research and Treatment Act of 2015 (All provisions) H.R. 1130 Chronic Kidney Disease Improvement in Research and Treatment Act of 2015 (All provisions)
Medicare Access and CHIP Reauthorization Act of 2015
Client: DAVITA INC. · Firm: PURPLE ADVOCACY, LLC
CMS call letter for Medicare Advantage with a focus on rate setting and risk adjustment CMS regulations related to the treatment of Medicare Part C and Part D CMS regulations pertaining to reimbursement rates for ESRD-related services. H.R. 2 the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) (All provisions) S. 598 Chronic Kidney Disease Improvement in Research and Treatment Act of 2015 (All provisions) H.R. 1130 Chronic Kidney Disease Improvement in Research and Treatment Act of 2015 (All provisions)
Medicare Access and CHIP Reauthorization Act of 2015
Client: DAVITA INC. · Firm: PURPLE ADVOCACY, LLC
CMS call letter for Medicare Advantage with a focus on rate setting and risk adjustment CMS regulations related to the treatment of Medicare Part C and Part D CMS regulations pertaining to reimbursement rates for ESRD-related services. H.R. 2 the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) (All provisions) S. 598 Chronic Kidney Disease Improvement in Research and Treatment Act of 2015 (All provisions) H.R. 1130 Chronic Kidney Disease Improvement in Research and Treatment Act of 2015 (All provisions)
Chronic Kidney Disease Improvement in Research and Treatment Act of 2015
Client: DAVITA INC. · Firm: PURPLE ADVOCACY, LLC
CMS call letter for Medicare Advantage with a focus on rate setting and risk adjustment CMS regulations related to the treatment of Medicare Part C and Part D CMS regulations pertaining to reimbursement rates for ESRD-related services. H.R. 2 the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) (All provisions) S. 598 Chronic Kidney Disease Improvement in Research and Treatment Act of 2015 (All provisions) H.R. 1130 Chronic Kidney Disease Improvement in Research and Treatment Act of 2015 (All provisions)
Chronic Kidney Disease Improvement in Research and Treatment Act of 2015
Client: DAVITA INC. · Firm: PURPLE ADVOCACY, LLC
CMS call letter for Medicare Advantage with a focus on rate setting and risk adjustment CMS regulations related to the treatment of Medicare Part C and Part D CMS regulations pertaining to reimbursement rates for ESRD-related services. H.R. 2 the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) (All provisions) S. 598 Chronic Kidney Disease Improvement in Research and Treatment Act of 2015 (All provisions) H.R. 1130 Chronic Kidney Disease Improvement in Research and Treatment Act of 2015 (All provisions)
End-stage renal disease reimbursement and policies related to the Medicare End Stage Renal Disease Prospective Payment System; and issues related to state-based health insurance exchanges and patient protections for patients under the Affordable Care Act (Public Law 112-25). Final Regulations issued by CMS regading Medicare payments for services for people living with ESRD. H.R. 4302- Protecting Access to Medicare Act of 2014 and provisions related to the treatment of bundled payments for ESRD providers participating in Medicare. HR 4814 The Chronic Kidney Disease Improvement in Research and Treatment Act of 2014. S. 2501 Hospital Readmissions Program Accuracy and Accountability Act.
End-stage renal disease reimbursement and policies related to the Medicare End Stage Renal Disease Prospective Payment System; and issues related to state-based health insurance exchanges and patient protections for patients under the Affordable Care Act (Public Law 112-25). Final Regulations issued by CMS regading Medicare payments for services for people living with ESRD. H.R. 4302- Protecting Access to Medicare Act of 2014 and provisions related to the treatment of bundled payments for ESRD providers participating in Medicare. HR 4814 The Chronic Kidney Disease Improvement in Research and Treatment Act of 2014.
End-stage renal disease reimbursement and policies related to the Medicare End Stage Renal Disease Prospective Payment System; and issues related to state-based health insurance exchanges and patient protections for patients under the Affordable Care Act (Public Law 112-25). Final Regulations issued by CMS regading Medicare payments for services for people living with ESRD. H.R. 4302- Protecting Access to Medicare Act of 2014 and provisions related to the treatment of bundled payments for ESRD providers participating in Medicare.
Chronic Kidney Disease Improvement in Research and Treatment Act of 2014
Client: DAVITA INC. · Firm: PURPLE ADVOCACY, LLC
End-stage renal disease reimbursement and policies related to the Medicare End Stage Renal Disease Prospective Payment System; and issues related to state-based health insurance exchanges and patient protections for patients under the Affordable Care Act (Public Law 112-25). Final Regulations issued by CMS regading Medicare payments for services for people living with ESRD. H.R. 4302- Protecting Access to Medicare Act of 2014 and provisions related to the treatment of bundled payments for ESRD providers participating in Medicare. HR 4814 The Chronic Kidney Disease Improvement in Research and Treatment Act of 2014. S. 2501 Hospital Readmissions Program Accuracy and Accountability Act.
Chronic Kidney Disease Improvement in Research and Treatment Act of 2014
Client: DAVITA INC. · Firm: PURPLE ADVOCACY, LLC
End-stage renal disease reimbursement and policies related to the Medicare End Stage Renal Disease Prospective Payment System; and issues related to state-based health insurance exchanges and patient protections for patients under the Affordable Care Act (Public Law 112-25). HR 4814 The Chronic Kidney Disease Improvement in Research and Treatment Act of 2014. CMS regulations related to the treatment of Medicare Part C and D.
Chronic Kidney Disease Improvement in Research and Treatment Act of 2014
Client: DAVITA INC. · Firm: PURPLE ADVOCACY, LLC
End-stage renal disease reimbursement and policies related to the Medicare End Stage Renal Disease Prospective Payment System; and issues related to state-based health insurance exchanges and patient protections for patients under the Affordable Care Act (Public Law 112-25). Final Regulations issued by CMS regading Medicare payments for services for people living with ESRD. H.R. 4302- Protecting Access to Medicare Act of 2014 and provisions related to the treatment of bundled payments for ESRD providers participating in Medicare. HR 4814 The Chronic Kidney Disease Improvement in Research and Treatment Act of 2014.
Chronic Kidney Disease Improvement in Research and Treatment Act of 2014
Client: DAVITA INC. · Firm: PURPLE ADVOCACY, LLC
End-stage renal disease reimbursement and policies related to the Medicare End Stage Renal Disease Prospective Payment System; and issues related to state-based health insurance exchanges and patient protections for patients under the Affordable Care Act (Public Law 112-25). HR 4814 The Chronic Kidney Disease Improvement in Research and Treatment Act of 2014. CMS regulations related to the treatment of Medicare Part C and D.
Chronic Kidney Disease Improvement in Research and Treatment Act of 2014
Client: DAVITA INC. · Firm: PURPLE ADVOCACY, LLC
End-stage renal disease reimbursement and policies related to the Medicare End Stage Renal Disease Prospective Payment System; and issues related to state-based health insurance exchanges and patient protections for patients under the Affordable Care Act (Public Law 112-25). HR 4814 The Chronic Kidney Disease Improvement in Research and Treatment Act of 2014. CMS regulations related to the treatment of Medicare Part C and D.
Motorsports Fairness and Permanency Act
Client: NATIONAL ASSOCIATION FOR STOCK CAR AUTO RACING · Firm: PURPLE ADVOCACY, LLC
Issue education related to the depreciation of motorsports entertainment complex facilities; S.1826/H.R.4933, the Motorsports Fairness and Permanency Act; and the Expiring Provisions Improvement Reform and Efficiency (EXPIRE) Act.
Motorsports Fairness and Permanency Act
Client: NATIONAL ASSOCIATION FOR STOCK CAR AUTO RACING · Firm: PURPLE ADVOCACY, LLC
Issue education related to the depreciation of motorsports entertainment complex facilities; S.1826/H.R.4933, the Motorsports Fairness and Permanency Act; and the Expiring Provisions Improvement Reform and Efficiency (EXPIRE) Act.
Motorsports Fairness and Permanency Act
Client: NATIONAL ASSOCIATION FOR STOCK CAR AUTO RACING · Firm: PURPLE ADVOCACY, LLC
Issue education related to the depreciation of motorsports entertainment complex facilities; S.1826/H.R.4933, the Motorsports Fairness and Permanency Act; and the Expiring Provisions Improvement Reform and Efficiency (EXPIRE) Act.
Motorsports Fairness and Permanency Act
Client: NATIONAL ASSOCIATION FOR STOCK CAR AUTO RACING · Firm: PURPLE ADVOCACY, LLC
Issue education related to the depreciation of motorsports entertainment complex facilities; S.1826/H.R.4933, the Motorsports Fairness and Permanency Act; and the Expiring Provisions Improvement Reform and Efficiency (EXPIRE) Act.
Motorsports Fairness and Permanency Act
Client: NATIONAL ASSOCIATION FOR STOCK CAR AUTO RACING · Firm: PURPLE ADVOCACY, LLC
Issue education related to the depreciation of motorsports entertainment complex facilities; S.1826/H.R.4933, the Motorsports Fairness and Permanency Act; and the Expiring Provisions Improvement Reform and Efficiency (EXPIRE) Act.
Motorsports Fairness and Permanency Act
Client: NATIONAL ASSOCIATION FOR STOCK CAR AUTO RACING · Firm: PURPLE ADVOCACY, LLC
Issue education related to the depreciation of motorsports entertainment complex facilities; S.1826/H.R.4933, the Motorsports Fairness and Permanency Act; and the Expiring Provisions Improvement Reform and Efficiency (EXPIRE) Act.
Motorsports Fairness and Permanency Act
Client: NATIONAL ASSOCIATION FOR STOCK CAR AUTO RACING · Firm: PURPLE ADVOCACY, LLC
Issue education related to the depreciation of motorsports entertainment complex facilities; S.1826, the Motorsports Fairness and Permanency Act; and the Expiring Provisions Improvement Reform and Efficiency (EXPIRE) Act.
Hospital Readmissions Program Accuracy and Accountability Act of 2014
Client: DAVITA INC. · Firm: PURPLE ADVOCACY, LLC
End-stage renal disease reimbursement and policies related to the Medicare End Stage Renal Disease Prospective Payment System; and issues related to state-based health insurance exchanges and patient protections for patients under the Affordable Care Act (Public Law 112-25). Final Regulations issued by CMS regading Medicare payments for services for people living with ESRD. H.R. 4302- Protecting Access to Medicare Act of 2014 and provisions related to the treatment of bundled payments for ESRD providers participating in Medicare. HR 4814 The Chronic Kidney Disease Improvement in Research and Treatment Act of 2014. S. 2501 Hospital Readmissions Program Accuracy and Accountability Act.
Motorsports Fairness and Permanency Act
Client: NATIONAL ASSOCIATION FOR STOCK CAR AUTO RACING · Firm: PURPLE ADVOCACY, LLC
Issue education related to the depreciation of motorsports entertainment complex facilities and S.1826, the Motorsports Fairness and Permanency Act.
End-stage renal disease reimbursement and policies related to the Medicare End Stage Renal Disease Prospective Payment System; the Affordable Care Act (Public Law 112-25); H.R. 8 - The American Taxpayer Relief Act of 2012, and subsequent rule making.
End-stage renal disease reimbursement and policies related to the Medicare End Stage Renal Disease Prospective Payment System; the Affordable Care Act (Public Law 112-25); H.R. 8 - The American Taxpayer Relief Act of 2012, and subsequent rule making; S. Con. Res. 8 - Senate Budget Resolution for FY 2014; and H.J. Res 59 - Continuing Appropriations Resolution for 2014.
End-stage renal disease reimbursement and policies related to the Medicare End Stage Renal Disease Prospective Payment System, the Affordable Care Act (Public Law 112-25), and H.R. 8 - The American Taxpayer Relief Act of 2012.
End-stage renal disease reimbursement and policies related to the Medicare End Stage Renal Disease Prospective Payment System, the Affordable Care Act (Public Law 112-25), and H.R. 8 - The American Taxpayer Relief Act of 2012.
End-stage renal disease reimbursement and policies related to the Medicare End Stage Renal Disease Prospective Payment System; the Affordable Care Act (Public Law 112-25); H.R. 8 - The American Taxpayer Relief Act of 2012, and subsequent rule making; S. Con. Res. 8 - Senate Budget Resolution for FY 2014; and H.J. Res 59 - Continuing Appropriations Resolution for 2014.
End-stage renal disease reimbursement and policies related to the Medicare End Stage Renal Disease Prospective Payment System; the Affordable Care Act (Public Law 112-25); H.R. 8 - The American Taxpayer Relief Act of 2012, and subsequent rule making.
End-stage renal disease reimbursement and policies related to the Medicare End Stage Renal Disease Prospective Payment System; the Affordable Care Act (Public Law 112-25); H.R. 8 - The American Taxpayer Relief Act of 2012, and subsequent rule making.
End-stage renal disease reimbursement and policies related to the Medicare End Stage Renal Disease Prospective Payment System; the Affordable Care Act (Public Law 112-25); H.R. 8 - The American Taxpayer Relief Act of 2012, and subsequent rule making.
Proposing an amendment to the Constitution of the United States to protect the rights of crime victims.
Client: DAVITA INC. · Firm: PURPLE ADVOCACY, LLC
End-stage renal disease reimbursement and policies related to the Medicare End Stage Renal Disease Prospective Payment System; the Affordable Care Act (Public Law 112-25); H.R. 8 - The American Taxpayer Relief Act of 2012, and subsequent rule making; S. Con. Res. 8 - Senate Budget Resolution for FY 2014; and H.J. Res 59 - Continuing Appropriations Resolution for 2014.
Proposing an amendment to the Constitution of the United States to protect the rights of crime victims.
Client: DAVITA INC. · Firm: PURPLE ADVOCACY, LLC
End-stage renal disease reimbursement and policies related to the Medicare End Stage Renal Disease Prospective Payment System; the Affordable Care Act (Public Law 112-25); H.R. 8 - The American Taxpayer Relief Act of 2012, and subsequent rule making; S. Con. Res. 8 - Senate Budget Resolution for FY 2014; and H.J. Res 59 - Continuing Appropriations Resolution for 2014.
American Taxpayer Relief Act of 2012
Client: PARTNERSHIP FOR QUALITY HOME HEALTHCARE · Firm: PURPLE ADVOCACY, LLC
H.R. 8 - American Taxpayer Relief Act of 2012- Medicare related offsets for the Sustained Growth Rate provision; and other outreach related to home healthcare policy, reimbursement and access issues.
End-stage renal disease reimbursement and policies related to the new End Stage Renal Disease Prospective Payment System; and the new health care law (Public Law 112-25). H.R. 8 - American Taxpayer Relief Act of 2012, specifically Medicare related offsets and impact to the ESRD bundled payment system.
End-stage renal disease reimbursement and policies related to the new End Stage Renal Disease Prospective Payment System; and the new health care law (Public Law 112-25). H.R. 8 - American Taxpayer Relief Act of 2012, specifically Medicare related offsets and impact to the ESRD bundled payment system.
American Taxpayer Relief Act of 2012
Client: PARTNERSHIP FOR QUALITY HOME HEALTHCARE · Firm: PURPLE ADVOCACY, LLC
H.R. 8 - American Taxpayer Relief Act of 2012- Medicare related offsets for the Sustained Growth Rate provision; and other outreach related to home healthcare policy, reimbursement and access issues.
Defense budget and appropriations as related to shipbuilding.
Defense budget and appropriations as related to shipbuilding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION FOR STOCK CAR AUTO RACING via PURPLE ADVOCACY, LLC
2015 · third_quarter · Q3
Issue education related to the depreciation of motorsports entertainment complex facilities
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HUNTINGTON INGALLS INDUSTRIES INC. via PURPLE ADVOCACY, LLC
2015 · third_quarter · Q3
Defense budget and appropriations as related to shipbuilding.
Defense budget and appropriations as related to shipbuilding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HUNTINGTON INGALLS INDUSTRIES INC. via PURPLE ADVOCACY, LLC
2015 · second_quarter · Q2
Defense budget and appropriations as related to shipbuilding.
Defense budget and appropriations as related to shipbuilding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION FOR STOCK CAR AUTO RACING via PURPLE ADVOCACY, LLC
2015 · second_quarter · Q2
Issue education related to the depreciation of motorsports entertainment complex facilities
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DAVITA INC. via PURPLE ADVOCACY, LLC
2015 · first_quarter · 1T
CMS call letter for Medicare Advantage with a focus on rate setting and risk adjustment CMS regulations related to the treatment of Medicare Part C and Part D CMS regulations pertaining to reimbursement rates for ESRD-related services. H.R. 2 the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) (All provisions) S. 598 Chronic Kidney Disease Improvement in Research and Treatment Act of 2015 (All provisions) H.R. 1130 Chronic Kidney Disease Improvement in Research and Treatment Act of 2015 (All provisions)
CMS call letter for Medicare Advantage with a focus on rate setting and risk adjustment CMS regulations related to the treatment of Medicare Part C and Part D CMS regulations pertaining to reimbursement rates for ESRD-related services. H.R. 2 the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) (All provisions) S. 598 Chronic Kidney Disease Improvement in Research and Treatment Act of 2015 (All provisions) H.R. 1130 Chronic Kidney Disease Improvement in Research and Treatment Act of 2015 (All provisions)
HUNTINGTON INGALLS INDUSTRIES INC. via PURPLE ADVOCACY, LLC
2015 · first_quarter · Q1
Defense budget and appropriations as related to shipbuilding.
Defense budget and appropriations as related to shipbuilding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION FOR STOCK CAR AUTO RACING via PURPLE ADVOCACY, LLC
2015 · first_quarter · Q1
Issue education related to the depreciation of motorsports entertainment complex facilities
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DAVITA INC. via PURPLE ADVOCACY, LLC
2014 · fourth_quarter · Q4
Legislative provisions related to veteran dialysis facilities
End-stage renal disease reimbursement and policies related to the Medicare End Stage Renal Disease Prospective Payment System; and issues related to state-based health insurance exchanges and patient protections for patients under the Affordable Care Act (Public Law 112-25). HR 4814 The Chronic Kidney Disease Improvement in Research and Treatment Act of 2014. CMS regulations related to the treatment of Medicare Part C and D.
End-stage renal disease reimbursement and policies related to the Medicare End Stage Renal Disease Prospective Payment System; and issues related to state-based health insurance exchanges and patient protections for patients under the Affordable Care Act (Public Law 112-25). HR 4814 The Chronic Kidney Disease Improvement in Research and Treatment Act of 2014. CMS regulations related to the treatment of Medicare Part C and D.
HUNTINGTON INGALLS INDUSTRIES INC. via PURPLE ADVOCACY, LLC
2014 · fourth_quarter · Q4
Defense budget and appropriations as related to shipbuilding.
Defense budget and appropriations as related to shipbuilding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION FOR STOCK CAR AUTO RACING via PURPLE ADVOCACY, LLC
2014 · fourth_quarter · Q4
Issue education related to traffic safety.
Issue education related to the depreciation of motorsports entertainment complex facilities; S.1826/H.R.4933, the Motorsports Fairness and Permanency Act; and the Expiring Provisions Improvement Reform and Efficiency (EXPIRE) Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HUNTINGTON INGALLS INDUSTRIES INC. via PURPLE ADVOCACY, LLC
2014 · third_quarter · Q3
Defense budget and appropriations as related to shipbuilding.
Defense budget and appropriations as related to shipbuilding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION FOR STOCK CAR AUTO RACING via PURPLE ADVOCACY, LLC
2014 · third_quarter · Q3
Issue education related to the depreciation of motorsports entertainment complex facilities; S.1826/H.R.4933, the Motorsports Fairness and Permanency Act; and the Expiring Provisions Improvement Reform and Efficiency (EXPIRE) Act.
Issue education related to traffic safety.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT)
DAVITA INC. via PURPLE ADVOCACY, LLC
2014 · third_quarter · Q3
End-stage renal disease reimbursement and policies related to the Medicare End Stage Renal Disease Prospective Payment System; and issues related to state-based health insurance exchanges and patient protections for patients under the Affordable Care Act (Public Law 112-25). HR 4814 The Chronic Kidney Disease Improvement in Research and Treatment Act of 2014. CMS regulations related to the treatment of Medicare Part C and D.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENERAL MOTORS COMPANY via PURPLE ADVOCACY, LLC
2014 · third_quarter · 3T
Auto Industry Issues, including sharing information about GM facilities and progress on GM restructuring. Education and communication related to vehicle recall.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HUNTINGTON INGALLS INDUSTRIES INC. via PURPLE ADVOCACY, LLC
2014 · second_quarter · Q2
Defense budget and appropriations as related to shipbuilding.
Defense budget and appropriations as related to shipbuilding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION FOR STOCK CAR AUTO RACING via PURPLE ADVOCACY, LLC
2014 · second_quarter · Q2
Issue education related to traffic safety.
Issue education related to the depreciation of motorsports entertainment complex facilities; S.1826/H.R.4933, the Motorsports Fairness and Permanency Act; and the Expiring Provisions Improvement Reform and Efficiency (EXPIRE) Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT)
DAVITA INC. via PURPLE ADVOCACY, LLC
2014 · second_quarter · Q2
End-stage renal disease reimbursement and policies related to the Medicare End Stage Renal Disease Prospective Payment System; and issues related to state-based health insurance exchanges and patient protections for patients under the Affordable Care Act (Public Law 112-25). Final Regulations issued by CMS regading Medicare payments for services for people living with ESRD. H.R. 4302- Protecting Access to Medicare Act of 2014 and provisions related to the treatment of bundled payments for ESRD providers participating in Medicare. HR 4814 The Chronic Kidney Disease Improvement in Research and Treatment Act of 2014. S. 2501 Hospital Readmissions Program Accuracy and Accountability Act.
End-stage renal disease reimbursement and policies related to the Medicare End Stage Renal Disease Prospective Payment System; and issues related to state-based health insurance exchanges and patient protections for patients under the Affordable Care Act (Public Law 112-25). Final Regulations issued by CMS regading Medicare payments for services for people living with ESRD. H.R. 4302- Protecting Access to Medicare Act of 2014 and provisions related to the treatment of bundled payments for ESRD providers participating in Medicare. HR 4814 The Chronic Kidney Disease Improvement in Research and Treatment Act of 2014.
GENERAL MOTORS COMPANY via PURPLE ADVOCACY, LLC
2014 · second_quarter · Q2
Auto Industry Issues, including sharing information about GM facilities and progress on GM restructuring. Education and communication related to vehicle recall.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENERAL MOTORS COMPANY via PURPLE ADVOCACY, LLC
2014 · second_quarter · RR
Automotive transportation and industry issues; tax issues, and safety issues.
Automotive transportation and industry issues; tax issues, and safety issues.
Automotive transportation and industry issues; tax issues, and safety issues.
NATIONAL ASSOCIATION FOR STOCK CAR AUTO RACING via PURPLE ADVOCACY, LLC
2014 · first_quarter · Q1
Issue education related to the depreciation of motorsports entertainment complex facilities; S.1826, the Motorsports Fairness and Permanency Act; and the Expiring Provisions Improvement Reform and Efficiency (EXPIRE) Act.
Issue education related to traffic safety.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT)
PARTNERSHIP FOR QUALITY HOME HEALTHCARE via PURPLE ADVOCACY, LLC
2014 · first_quarter · 1T
Congressional outreach related to home healthcare policy, reimbursement and access to care issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HUNTINGTON INGALLS INDUSTRIES INC. via PURPLE ADVOCACY, LLC
2014 · first_quarter · Q1
Defense budget and appropriations [FY14 Defense Authorization, FY14 Defense Appropriations] as related to shipbuilding.
Defense budget and appropriations as related to shipbuilding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DAVITA INC. via PURPLE ADVOCACY, LLC
2014 · first_quarter · Q1
End-stage renal disease reimbursement and policies related to the Medicare End Stage Renal Disease Prospective Payment System; and issues related to state-based health insurance exchanges and patient protections for patients under the Affordable Care Act (Public Law 112-25). Final Regulations issued by CMS regading Medicare payments for services for people living with ESRD. H.R. 4302- Protecting Access to Medicare Act of 2014 and provisions related to the treatment of bundled payments for ESRD providers participating in Medicare.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION FOR STOCK CAR AUTO RACING via PURPLE ADVOCACY, LLC
2013 · fourth_quarter · 4A
Issue education related to the sponsorship of motorsports
Issue education related to the depreciation of motorsports entertainment complex facilities and S.1826, the Motorsports Fairness and Permanency Act.
Issue education related to traffic safety.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Highway Traffic Safety Administration (NHTSA), SENATE, Transportation, Dept of (DOT)
DAVITA INC. via PURPLE ADVOCACY, LLC
2013 · fourth_quarter · Q4
End-stage renal disease reimbursement and policies related to the Medicare End Stage Renal Disease Prospective Payment System; the Affordable Care Act (Public Law 112-25); H.R. 8 - The American Taxpayer Relief Act of 2012, and subsequent rule making; S. Con. Res. 8 - Senate Budget Resolution for FY 2014; and H.J. Res 59 - Continuing Appropriations Resolution for 2014.
End-stage renal disease reimbursement and policies related to the Medicare End Stage Renal Disease Prospective Payment System; the Affordable Care Act (Public Law 112-25); H.R. 8 - The American Taxpayer Relief Act of 2012, and subsequent rule making; S. Con. Res. 8 - Senate Budget Resolution for FY 2014; and H.J. Res 59 - Continuing Appropriations Resolution for 2014.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HUNTINGTON INGALLS INDUSTRIES INC. via PURPLE ADVOCACY, LLC
2013 · fourth_quarter · Q4
Defense budget and appropriations [FY14 Defense Authorization, FY14 Defense Appropriations] as related to shipbuilding.
Defense budget and appropriations [FY14 Defense Authorization, FY14 Defense Appropriations] as related to shipbuilding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTNERSHIP FOR QUALITY HOME HEALTHCARE via PURPLE ADVOCACY, LLC
2013 · fourth_quarter · Q4
Congressional outreach related to home healthcare policy, reimbursement and access to care issues.
Congressional outreach related to home healthcare policy, reimbursement and access to care issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTNERSHIP FOR QUALITY HOME HEALTHCARE via PURPLE ADVOCACY, LLC
2013 · third_quarter · Q3
Congressional outreach related to home healthcare policy, reimbursement and access to care issues.
Congressional outreach related to home healthcare policy, reimbursement and access to care issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HUNTINGTON INGALLS INDUSTRIES INC. via PURPLE ADVOCACY, LLC
2013 · third_quarter · Q3
Defense budget and appropriations [FY14 Defense Authorization, FY14 Defense Appropriations] as related to shipbuilding.
Defense budget and appropriations [FY14 Defense Authorization, FY14 Defense Appropriations] as related to shipbuilding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DAVITA INC. via PURPLE ADVOCACY, LLC
2013 · third_quarter · Q3
End-stage renal disease reimbursement and policies related to the Medicare End Stage Renal Disease Prospective Payment System; the Affordable Care Act (Public Law 112-25); H.R. 8 - The American Taxpayer Relief Act of 2012, and subsequent rule making.
End-stage renal disease reimbursement and policies related to the Medicare End Stage Renal Disease Prospective Payment System; the Affordable Care Act (Public Law 112-25); H.R. 8 - The American Taxpayer Relief Act of 2012, and subsequent rule making.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION FOR STOCK CAR AUTO RACING via PURPLE ADVOCACY, LLC
2013 · third_quarter · Q3
Issue education related to the sponsorship of motorsports
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION FOR STOCK CAR AUTO RACING via PURPLE ADVOCACY, LLC
2013 · second_quarter · Q2
Issue education related to sponsorships of professional sports [H.R. 1960 NDAA FY14]
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTNERSHIP FOR QUALITY HOME HEALTHCARE via PURPLE ADVOCACY, LLC
2013 · second_quarter · Q2
Congressional outreach related to home healthcare policy, reimbursement and access to care issues.
Congressional outreach related to home healthcare policy, reimbursement and access to care issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HUNTINGTON INGALLS INDUSTRIES INC. via PURPLE ADVOCACY, LLC
2013 · second_quarter · Q2
Defense budget and appropriations [FY14 Defense Authorization, FY14 Defense Appropriations] as related to shipbuilding.
Defense budget and appropriations [FY14 Defense Authorization, FY14 Defense Appropriations] as related to shipbuilding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DAVITA INC. via PURPLE ADVOCACY, LLC
2013 · second_quarter · Q2
End-stage renal disease reimbursement and policies related to the Medicare End Stage Renal Disease Prospective Payment System; the Affordable Care Act (Public Law 112-25); H.R. 8 - The American Taxpayer Relief Act of 2012, and subsequent rule making.
End-stage renal disease reimbursement and policies related to the Medicare End Stage Renal Disease Prospective Payment System; the Affordable Care Act (Public Law 112-25); H.R. 8 - The American Taxpayer Relief Act of 2012, and subsequent rule making.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HUNTINGTON INGALLS INDUSTRIES INC. via PURPLE ADVOCACY, LLC
2013 · first_quarter · Q1
Defense budget and appropriations [FY13 Defense Authorization, FY13 Defense Appropriations, FY13 Continuing Resolution legislation] and issues related to sequestration.
Defense budget and appropriations [FY13 Defense Authorization, FY13 Defense Appropriations, FY13 Continuing Resolution legislation] and issues related to sequestration.
Filing targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
NATIONAL ASSOCIATION FOR STOCK CAR AUTO RACING via PURPLE ADVOCACY, LLC
2013 · first_quarter · Q1
Issue education related to sponsorships of professional sports.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTNERSHIP FOR QUALITY HOME HEALTHCARE via PURPLE ADVOCACY, LLC
2013 · first_quarter · Q1
Congressional outreach related to home healthcare policy, reimbursement and access to care issues.
Congressional outreach related to home healthcare policy, reimbursement and access to care issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DAVITA INC. via PURPLE ADVOCACY, LLC
2013 · first_quarter · Q1
End-stage renal disease reimbursement and policies related to the Medicare End Stage Renal Disease Prospective Payment System, the Affordable Care Act (Public Law 112-25), and H.R. 8 - The American Taxpayer Relief Act of 2012.
End-stage renal disease reimbursement and policies related to the Medicare End Stage Renal Disease Prospective Payment System, the Affordable Care Act (Public Law 112-25), and H.R. 8 - The American Taxpayer Relief Act of 2012.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION FOR STOCK CAR AUTO RACING via PURPLE ADVOCACY, LLC
2012 · fourth_quarter · Q4
Issue education related to sponsorships of professional sports.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HUNTINGTON INGALLS INDUSTRIES INC. via PURPLE ADVOCACY, LLC
2012 · fourth_quarter · Q4
Defense budget and appropriations [FY13 Defense Authorization, FY13 Defense Appropriations, FY13 Continuing Resolution legislation] and issues related to sequestration.
Defense budget and appropriations [FY13 Defense Authorization, FY13 Defense Appropriations, FY13 Continuing Resolution legislation] and issues related to sequestration.
Filing targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
2012 · fourth_quarter · 4T
Strategic guidance related to telecommunications issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTNERSHIP FOR QUALITY HOME HEALTHCARE via PURPLE ADVOCACY, LLC
2012 · fourth_quarter · Q4
H.R. 8 - American Taxpayer Relief Act of 2012- Medicare related offsets for the Sustained Growth Rate provision; and other outreach related to home healthcare policy, reimbursement and access issues.
H.R. 8 - American Taxpayer Relief Act of 2012- Medicare related offsets for the Sustained Growth Rate provision; and other outreach related to home healthcare policy, reimbursement and access issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DAVITA INC. via PURPLE ADVOCACY, LLC
2012 · fourth_quarter · Q4
End-stage renal disease reimbursement and policies related to the new End Stage Renal Disease Prospective Payment System; and the new health care law (Public Law 112-25). H.R. 8 - American Taxpayer Relief Act of 2012, specifically Medicare related offsets and impact to the ESRD bundled payment system.
End-stage renal disease reimbursement and policies related to the new End Stage Renal Disease Prospective Payment System; and the new health care law (Public Law 112-25). H.R. 8 - American Taxpayer Relief Act of 2012, specifically Medicare related offsets and impact to the ESRD bundled payment system.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HUNTINGTON INGALLS INDUSTRIES INC. via PURPLE ADVOCACY, LLC
2012 · third_quarter · Q3
Department of Defense budget and appropriations [H.R. 5856 Department of Defense Appropriations Act, 2013] and issues related to 2013 sequestration.
Department of Defense budget and appropriations [H.R. 5856 Department of Defense Appropriations Act, 2013] and issues related to 2013 sequestration.
Filing targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
TENNESSEE WALKING SHOW HORSE ORGANIZATION via PURPLE ADVOCACY, LLC
2012 · third_quarter · 3T
Education and outreach to promote organizational awareness.
Education and outreach to promote organizational awareness.
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
2012 · third_quarter · Q3
Strategic guidance related to telecommunications issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTNERSHIP FOR QUALITY HOME HEALTHCARE via PURPLE ADVOCACY, LLC
2012 · third_quarter · Q3
Outreach related to home healthcare policy, reimbursement and access issues.
Outreach related to home healthcare policy, reimbursement and access issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION FOR STOCK CAR AUTO RACING via PURPLE ADVOCACY, LLC
2012 · third_quarter · RA
Issues related to sponsorships of professional sports.
NATIONAL ASSOCIATION FOR STOCK CAR AUTO RACING via PURPLE ADVOCACY, LLC
2012 · third_quarter · Q3
H.AMDT.1380 to H.R.5856 [Department of Defense Appropriations Act, 2013]: An amendment sought to reduce funds for recruiting in the armed services, and apply the savings to the spending reduction account.
Filing targets: HOUSE OF REPRESENTATIVES
NATIONAL RETAIL FEDERATION via PURPLE ADVOCACY, LLC
2012 · third_quarter · 3T
Sales tax fairness
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DAVITA INC. via PURPLE ADVOCACY, LLC
2012 · third_quarter · Q3
Medicare end-stage renal disease reimbursement and policies related to the new Healthcare Exchange; Medicare reimbursement of ESRD related drugs
Medicare end-stage renal disease reimbursement and policies related to the new Healthcare Exchange; Medicare reimbursement of ESRD related drugs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION FOR STOCK CAR AUTO RACING via PURPLE ADVOCACY, LLC
2012 · third_quarter · RR
Issues related to sponsorships of professional sports.
PARTNERSHIP FOR QUALITY HOME HEALTHCARE via PURPLE ADVOCACY, LLC
2012 · third_quarter · RR
Home health policy and reimbursement issues
Home health policy and reimbursement issues
TENNESSEE WALKING SHOW HORSE ORGANIZATION via PURPLE ADVOCACY, LLC
2012 · third_quarter · RR
Education and outreach to promote awareness
Education and outreach to promote awareness
NATIONAL RETAIL FEDERATION via PURPLE ADVOCACY, LLC
2012 · second_quarter · Q2
Sales tax fairness
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HUNTINGTON INGALLS INDUSTRIES INC. via PURPLE ADVOCACY, LLC
2012 · second_quarter · Q2
Department of Defense budget and appropriations as related to shipbuilding; H.R. 5856 Department of Defense Appropriations Act, 2013
Department of Defense budget and appropriations as related to shipbuilding; H.R. 5856 Department of Defense Appropriations Act, 2013
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
2012 · second_quarter · Q2
Strategic guidance related to telecommunications issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DAVITA INC. via PURPLE ADVOCACY, LLC
2012 · second_quarter · Q2
Medicare end-stage renal disease reimbursement and policies related to Medicare Secondary Payor and subsidy provisions in the new Healthcare Exchange.
Medicare end-stage renal disease reimbursement and policies related to Medicare Secondary Payor and subsidy provisions in the new Healthcare Exchange
Medicare end-stage renal disease reimbursement and policies related to Medicare Secondary Payor and subsidy provisions in the new Healthcare Exchange.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · first_quarter · RR
Provide strategic counsel on issues related to cybersecurity and consumer privacy.
Education on issues related to veterans dialysis services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE